# PALMIRA (NCT03809988)

> PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03809988
- Phase: PHASE2
- Status: COMPLETED
- Sponsor: MedSIR
- Conditions: Breast Cancer; Advanced Breast Cancer; Hormone Receptor Positive Tumor; Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
- Interventions: Palbociclib; Endocrine therapy
- Enrollment: 198
- Primary outcome: PFS (Progression-free survival)

## Commentary we found

- X threads: 15
- YouTube: 7
- Podcasts: 4

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=palmira-nct03809988

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03809988", "email": "<work email>"}; the inbox owner confirms by the emailed link.